Silvec Biologics Competitors and Similar CompaniesClear all
Silvec Biologics's competitors and similar companies include Biohaven Pharmaceutical, Walvax Biotechnology, Relay Therapeutics and Zhaoke Ophthalmology.
 Silvec Biologics Silvec Biologics is a biotechnology company that specializes in vaccinating trees using RNA therapy. |  Biohaven Pharmaceutical Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system. |  Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. |  Relay Therapeutics Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities. |  Zhaoke Ophthalmology Zhaoke Ophthalmology (兆科眼科) is a company that produces and commercializes ophthalmic products. | |
Founding Date | Founding Date 2019 | Founding Date 2014 | Founding Date 2001 | Founding Date 2016 | Founding Date 2017 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Gaithersburg, US HQ | Locations New Haven, US HQ | Locations Kunming, CN HQ | Locations Cambridge, US HQ | Locations George Town, KY HQ |
Employees | Employees 129% increase | Employees 4343% increase | Employees 2,388 | Employees 2724% decrease | Employees 294 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.3 b | Valuation ($) 958.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) $15.4m (FY, 2025) | Revenue (est.) ¥32m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥615.2m (FY, 2025) | Cost of goods N/A | Cost of goods ¥15.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥1.8b (FY, 2025) | Gross profit N/A | Gross profit ¥16.8m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income ¥125.2m (FY, 2025) | Net income ($276.5m) (FY, 2025) | Net income (¥209m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 80m | Total funding raised $ 72.8m | Total funding raised $ 520m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Biohaven Pharmaceutical
HQ
New Haven, US
Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
View companyWalvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View companyRelay Therapeutics
HQ
Cambridge, US
Employees
272↓ 4% decrease
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
View companyZhaoke Ophthalmology
HQ
George Town, KY
Employees
294
Zhaoke Ophthalmology (兆科眼科) is a company that produces and commercializes ophthalmic products.
View company